Boothbay Fund Management, LLC Morphic Holding, Inc. Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$26.01 - $48.69 $291,520 - $545,717	11,208 New	11,208 $421,000
Q2 2021 Aug 16, 2021	SELL	$45.13 - $64.99 $239,098 - $344,317	-5,298 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$29.77 - $84.85 $1.45 Million - $4.13 Million	-48,728 Reduced 90.19%	5,298 $335,000
Q4 2020 Feb 12, 2021	BUY	$25.66 - $34.55 $1.39 Million - $1.87 Million	54,026 New	54,026 $1.81 Million

142

37.9M

13.5K

190K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.